Stage IV Rectal Cancer AJCC v8
Drug | Drug Name | Drug Description |
---|
Drug | Drug Name | Target | Type |
---|
Drug | Drug Name | Phase | Status | Count |
---|---|---|---|---|
DB06186 | Ipilimumab | 1 | Active Not Recruiting | 1 |
DB09035 | Nivolumab | 1 | Active Not Recruiting | 1 |
DB08896 | Regorafenib | 1 | Active Not Recruiting | 1 |
DB12001 | Abemaciclib | 1 / 2 | Active Not Recruiting | 1 |
DB15676 | Balstilimab | 1 / 2 | Recruiting | 1 |
DB00112 | Bevacizumab | 1 / 2 | Recruiting | 1 |
DB15387 | Bintrafusp alfa | 1 / 2 | Active Not Recruiting | 1 |
DB16651 | Botensilimab | 1 / 2 | Recruiting | 1 |
DB01373 | Calcium | 1 / 2 | Recruiting | 1 |
DB00002 | Cetuximab | 1 / 2 | Active Not Recruiting | 1 |
DB00544 | Fluorouracil | 1 / 2 | Recruiting | 1 |
DB00650 | Leucovorin | 1 / 2 | Recruiting | 1 |
DB11596 | Levoleucovorin | 1 / 2 | Recruiting | 1 |
DB09035 | Nivolumab | 1 / 2 | Recruiting | 1 |
DB00526 | Oxaliplatin | 1 / 2 | Recruiting | 1 |
DB00002 | Cetuximab | 2 | Recruiting | 1 |
DB11718 | Encorafenib | 2 | Recruiting | 1 |
DB09035 | Nivolumab | 2 | Recruiting | 1 |
DB01269 | Panitumumab | 2 | Active Not Recruiting | 1 |
DB08896 | Regorafenib | 2 | Active Not Recruiting | 1 |
DB12048 | Savolitinib | 2 | Terminated | 1 |
DB08937 | TAS-102 | 2 | Active Not Recruiting | 1 |
DB08937 | TAS-102 | 2 | Not Yet Recruiting | 1 |
DB09343 | Tipiracil | 2 | Active Not Recruiting | 1 |
DB09343 | Tipiracil | 2 | Not Yet Recruiting | 1 |
DB00072 | Trastuzumab | 2 | Not Yet Recruiting | 1 |
DB00432 | Trifluridine | 2 | Active Not Recruiting | 1 |
DB00432 | Trifluridine | 2 | Not Yet Recruiting | 1 |
DB11652 | Tucatinib | 2 | Not Yet Recruiting | 1 |